Pediatric Cancer Biomarkers Market Demand, Size and Competitive Analysis | TechSci Research

Global Pediatric Cancer Biomarkers Market was valued at USD 812.11 Million in 2023 and is expected to reach USD 1313.79 Million by 2029 with a CAGR of 8.52% during the forecast period. <table><tr><td>Pages</td><td>183</td></tr> <tr><td>Market Size</td><td>2023: USD 812.11 Million</td></tr> <tr><td>Forecast Market Size</td><td>2029: USD 1313.79 Million</td></tr> <tr><td>CAGR</td><td>2024-2029: 8.52%</td></tr> <tr><td>Fastest Growing Segment</td><td>Leukemia</td></tr> <tr><td>Largest Market</td><td>North America</td></tr> <tr><td>Key Players</td><td>1.F. Hoffmann-La Roche Ltd2.Abbott Laboratories Inc.3.Siemens Healthineers AG4.Thermo Fisher Scientific Inc.5.QIAGEN NV6.Myriad Genetics, Inc.7.Danaher Corporation8.Bio-Rad Laboratories, Inc.9.Agilent Technologies Inc.10.BIOMÉRIEUX SA</td></tr> </table>

全球儿童癌症生物标志物市场在2023年达到了8.121亿美元的价值，预计到2029年将达到13.1379亿美元，预测期内年复合增长率（CAGR）为8.52%。

<table>
<tr>
<td>页数</td>
<td>183</td>
</tr>
<tr>
<td>市场规模</td>
<td>2023年：8.121亿美元</td>
</tr>
<tr>
<td>预测市场规模</td>
<td>2029年：13.1379亿美元</td>
</tr>
<tr>
<td>增长最快的细分市场</td>
<td>白血病</td>
</tr>
<tr>
<td>最大市场</td>
<td>北美</td>
</tr>
<tr>
<td>主要参与者</td>
<td>1. Hoffmann-La Roche Ltd
2. Abbott Laboratories Inc.
3. Siemens Healthineers AG
4. Thermo Fisher Scientific Inc.
5. QIAGEN NV
6. Myriad Genetics, Inc.
7. Danaher Corporation
8. Bio-Rad Laboratories, Inc.
9. Agilent Technologies Inc.
10. BIOMÉRIEUX SA</td>
</tr>
</table>